The expression of FLNA and CLU in PBMCs as a novel screening marker for hepatocellular carcinoma
Abstract Early detection improves survival and increases curative probability in hepatocellular carcinoma (HCC). Peripheral blood mononuclear cells (PBMCs) can provide an inexpensive, less-invasive and highly accurate method. The objective of this study is to find the potential marker for HCC screen...
Guardado en:
Autores principales: | Rathasapa Patarat, Shoji Riku, Pattapon Kunadirek, Natthaya Chuaypen, Pisit Tangkijvanich, Apiwat Mutirangura, Charoenchai Puttipanyalears |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9a12337f182644bfa0b70a760b398123 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of BHLHE40 expression in peripheral blood mononuclear cells as a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma
por: Pattapon Kunadirek, et al.
Publicado: (2021) -
Identification and validation of circulating miRNAs as potential new biomarkers for severe liver disease in patients with leptospirosis.
por: Natthaya Chuaypen, et al.
Publicado: (2021) -
An exploratory study on CLU, CR1 and PICALM and Parkinson disease.
por: Jianjun Gao, et al.
Publicado: (2011) -
Anti-inflammatory genes in PBMCs post-spontaneous intracerebral hemorrhage
por: Nguyen Doan, et al.
Publicado: (2021) -
Cardiovascular and connective tissue disorder features in FLNA-related PVNH patients: progress towards a refined delineation of this syndrome
por: Clarisse Billon, et al.
Publicado: (2021)